Literature DB >> 6166562

Neutralizing antibody spectrum determines the antigenic profiles of emerging mutants of visna virus.

O Narayan, J E Clements, D E Griffin, J S Wolinsky.   

Abstract

The visna viruses are antigenically related nononcogenic retroviruses of sheep. The original strain was isolated from the brain of a paralyzed sheep in Iceland during the 1940s. The prototype strains has been passed serially in sheep and has undergone progressive antigenic change. Previous reports have shown that such antigenic changes in visna virus can be reproduced in infected cell cultures treated with neutralizing antibody. We now show that the antigenic profiles of the emerging mutants directly reflect the nature of the selecting antibody. Mutants with minor antigenic changes were selected by "early" sera which had a limited neutralization range. Mutants with greater antigenic changes were selected by "late" sera with a wide neutralization range. Mutants selected by early sera emerged rapidly and consistently in cultures, and these were antigenically very similar to one another. Mutants rarely emerged in cultures treated with late sera, but these viruses showed major antigenic changes. The data suggest that the evolution of antigenic mutants of visna virus progresses by a series of minor mutations which accumulate under the selective pressure of antibody.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6166562      PMCID: PMC351556          DOI: 10.1128/iai.32.3.1045-1050.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Antigenic shift of visna virus in persistently infected sheep.

Authors:  O Narayan; D E Griffin; J Chase
Journal:  Science       Date:  1977-07-22       Impact factor: 47.728

2.  Pathogenesis of visna. I. Sequential virologic, serologic, and pathologic studies.

Authors:  G Pétursson; N Nathanson; G Georgsson; H Panitch; P A Pálsson
Journal:  Lab Invest       Date:  1976-10       Impact factor: 5.662

3.  Virus mutation during 'slow infection': temporal development and characterization of mutants of visna virus recovered from sheep.

Authors:  O Narayan; D E Griffin; J E Clements
Journal:  J Gen Virol       Date:  1978-11       Impact factor: 3.891

Review 4.  Visna-maedi in sheep.

Authors:  M Gudnadóttir
Journal:  Prog Med Virol       Date:  1974

5.  The structural polypeptides of RNA slow viruses.

Authors:  A T Haase; J R Baringer
Journal:  Virology       Date:  1974-01       Impact factor: 3.616

6.  Selection of antigenic mutants of influenza viruses. Isolation and peptide mapping of their hemagglutination proteins.

Authors:  W G Laver; R G Webster
Journal:  Virology       Date:  1968-02       Impact factor: 3.616

7.  Slow virus infection: replication and mechanisms of persistence of visna virus in sheep.

Authors:  O Narayan; D E Griffin; A M Silverstein
Journal:  J Infect Dis       Date:  1977-05       Impact factor: 5.226

8.  Visna virus infection of American lambs.

Authors:  O Narayan; A M Silverstein; D Price; R T Johnson
Journal:  Science       Date:  1974-03       Impact factor: 47.728

9.  Antigenic variants of influenza A virus obtained in vitro.

Authors:  L R Haaheim; G C Schild
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

10.  Antigenic drift in influenza A viruses. I. Selection and characterization of antigenic variants of A/PR/8/34 (HON1) influenza virus with monoclonal antibodies.

Authors:  W Gerhard; R G Webster
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

View more
  21 in total

1.  Direct determination of the point mutation rate of a murine retrovirus.

Authors:  R J Monk; F G Malik; D Stokesberry; L H Evans
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

Review 2.  Lentiviruses are etiological agents of chronic diseases in animals and acquired immunodeficiency syndrome in humans.

Authors:  O Narayan
Journal:  Can J Vet Res       Date:  1990-01       Impact factor: 1.310

3.  Characterization of a cDNA clone encoding the visna virus transactivating protein.

Authors:  J L Davis; J E Clements
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

Review 4.  The mutable vaccine for mutable viruses.

Authors:  Marilia Cascalho; Samuel J Balin; Jeffrey L Platt
Journal:  Immunotherapy       Date:  2017-06       Impact factor: 4.196

5.  Role of the host immune response in selection of equine infectious anemia virus variants.

Authors:  S Carpenter; L H Evans; M Sevoian; B Chesebro
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

Review 6.  Neurologic syndromes associated with retroviral infections: current views.

Authors:  W H Murphy
Journal:  Surv Immunol Res       Date:  1983

7.  Monoclonal antibodies against Aleutian disease virus distinguish virus strains and differentiate sites of virus replication from sites of viral antigen sequestration.

Authors:  R E Race; B Chesebro; M E Bloom; B Aasted; J Wolfinbarger
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

8.  The site of an immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 does not constitute the neutralization epitope.

Authors:  C Wilson; M S Reitz; K Aldrich; P J Klasse; J Blomberg; R C Gallo; M Robert-Guroff
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

9.  Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization.

Authors:  R J Grimaila; B A Fuller; P D Rennert; M B Nelson; M L Hammarskjöld; B Potts; M Murray; S D Putney; G Gray
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Identification of cell membrane proteins that bind visna virus.

Authors:  S E Crane; J Buzy; J E Clements
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.